The CIN framework assigns Verano Holdings a Neutral rating at 53/100, with conviction of 2 out of 5. Fundamentals carry 35 percent of the model, regulatory posture 25, market signal 25, and editorial density 15, with every pillar contribution auditable. Fundamentals leads the pillar table at 70, and is the main lever behind the Neutral conclusion. The offset comes from editorial at 30, which pulls the composite toward the middle of the band.
Under the hood, the data points sit as follows: reported revenue growth of -6.4 percent year over year, an operating margin of 7.2 percent, a market cap near 427 million. Each of those figures ties back to a specific input in the pillar breakdown. All inputs are drawn from primary regulatory filings, licensed fundamentals data, institutional pricing feeds, and CIN newsroom coverage density. Because every ticker in the CIN universe is scored on the same 336-name basis, Verano Holdings slots into a direct comparison rather than a bespoke narrative, and the score refreshes on the primary-source ingest cadence.
The clearest catalyst is the next quarterly print. Fundamentals contribute 70 of the composite, and either an acceleration in top-line growth or a stabilization of the operating margin would move the score higher; a deterioration on either would compress it.
Bullish and Bearish Analyst Opinions for VRNOF (VRNOF)
Cannabis Investor News aggregates analyst coverage, price targets, insider transactions, SEC filings, and financing activity for VRNOF (VRNOF), a cannabis-sector equity listed on OTCMKTS. Use this profile to compare bullish and bearish opinions, monitor Form 4 insider buys and sells, and review the latest quarterly results.
Bullish and bearish analyst opinions for Verano Holdings (VRNOF)
Bullish view. Verano Holdings is a top-tier US MSO with market-leading positions in Florida, New Jersey, and Illinois, plus a maturing Ohio adult-use footprint; bulls model operating-margin expansion as flagship states scale and note the brand portfolio (Zen Leaf retail, Encore concentrates, MUV medical) drives premium price capture that peers struggle to match.
Bearish view. Bearish views cite Florida adult-use referendum uncertainty, 280E cash-tax drag that limits reinvestment capacity, and MSO multiple compression that has held the whole peer group at deep discounts to consumer-staples benchmarks.
5-year weekly price history, intraday quotes, and 52-week range for VRNOF are maintained by Cannabis Investor News and refreshed throughout the trading day.